Autopsy report · NCT03960125

Photodynamic Therapy and Microvesicles

“The PI decided to move in another direction with his research.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Wright State University

Sponsor type

University, hospital or other

Conditions

Photodynamic Therapy; Microvesicle Particle

Interventions

Photodynamic Therapy; 4% Imipramine; Base Cream

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Metformin for Weight Loss in Schizophrenia
  “PI moved to different institution. Decided to concentrate on different studies.” (73% match in meaning)
• Cross-sectional Study on a Given Day Within the Paris Saint-Joseph Hospital Group
  “The PI decided it.” (70% match in meaning)
• Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
  “PI decided no longer to pursue” (67% match in meaning)
• Ultra High Field MRI of Focal Pediatric Epilepsy
  “PI moved to a different institution.” (67% match in meaning)
• Affective Processing in Depression and Epilepsy
  “PI wanted to discontinue study.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.